The effects of rosiglitazone on inflammatory biomarkers and adipokines in diabetic, hypertensive patients.
The present study demonstrated that in hypertensive, diabetic subjects, a rosiglitazone-based treatment strategy results in favourable changes in inflammatory biomarkers compare...